Abstract

Introduction Renal medullary carcinoma (RMC) is a rare and extremely aggressive tumor that is almost exclusively found in African American patients in the setting of sickle cell hemoglobinopathies, most commonly the sickle cell trait. Most patients have evidence of metastatic disease at the time of presentation, with an average reported length of survival in various case reports is 15 weeks from the time of diagnosis (range, 3-52 weeks). There is a case report in the literature of the use

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.